ROGER D WILT
Allopathic & Osteopathic Physicians|Family Medicine COLUMBUS, OH NPI 1801873013
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine OH Amgen Inc. All categories
General Payments — all program years on this page
$1,504.92
- Category: General Payments
- Program years: PY2018–2020
- Record count: 101
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $122.48 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $122.48 | 9 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $40.64 | 3 |
| Mylan Specialty L.P. | $19.40 | 1 |
| Kowa Pharmaceuticals America, Inc. | $14.85 | 1 |
| Novo Nordisk AS | $13.96 | 1 |
| Acerta Pharma LLC | $11.38 | 1 |
| Allergan Inc. | $11.19 | 1 |
| PFIZER INC. | $11.06 | 1 |
By program year
Records — PY2020 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 716723709 | Kowa Pharmaceuticals America, Inc. | $14.85 | 03/13/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 723582959 | Allergan, Inc. | $11.19 | 03/06/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 736278361 | AstraZeneca Pharmaceuticals LP | $11.38 | 01/28/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 741290327 | Amgen Inc. | $17.04 | 01/29/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 741290329 | Amgen Inc. | $11.28 | 01/31/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 741290331 | Amgen Inc. | $12.32 | 02/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 743672423 | PFIZER INC. | $11.06 | 02/27/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 744634845 | Novo Nordisk Inc | $13.96 | 03/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 751388051 | Mylan Specialty L.P. | $19.40 | 01/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.